FORM 2 - Corporate Substantial Shareholder Notice
 
Form Serial Number: CS20260629E00384 
1. Date of relevant event: 24/06/2026
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 00876
4. Name of listed corporation: Kaisa Health Group Holdings Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 103,632,754
7. Name of substantial shareholder: Kaisa Group Holdings Ltd. 
8. Registered office: Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman, KY1-1111, Cayman Islands
9. Principal place of business in Hong Kong: 30/F, The Center, 99 Queen's Road Central, Central, Hong Kong 
15. Exchange on which listed: Hong Kong
16. Name of listed parent and exchange on which parent is listed: N/A 
17. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position
1113The percentage level of your interest in the shares has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
2201Interest of corporation controlled by you
2,789,967 HKD 8.7500
3102Assets other than cash
Short position 
 
 
 
           
18. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position43,352,00942.99
19. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position46,141,97644.52
20. Capacity in which interests disclosed in Box 19 are held:
Capacity codeNumber of shares
2101Beneficial owner
Long position43,352,009
2201Interest of corporation controlled by you
Long position2,789,967

21. Further information in respect of derivative interests:
Derivatives codeNumber of shares
  
22. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Profit Vigorous Developments LimitedVistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands (Incorporated in BVI)Kaisa Group Holdings Limited100.00Y
Long position2,789,967

23. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
24. Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
25. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:
NamesAddressRelationship CodePercentage (%)
  
 
27. Supplementary information: Allotment of 2,789,967 Consolidated Shares as Consideration Shares to Profit Vigorous Developments Limited (a wholly-owned subsidiary of Kaisa Group Holdings Ltd.) upon completion of the acquisition of Embrace Blossom Limited on 24 June 2026, taking into account the effect of the Share Consolidation. Please refer to the announcement dated 18 March 2026 and the circular dated 2 June 2026 of Kaisa Health Group Holdings Limited for details.
28. Log/Serial Number of the previous form:
29. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 2: 29/06/2026
(dd/mm/yyyy)